pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·10h ago·2 min read
save

STAT+: Three questions with Whoop’s new CMO

In this edition of STAT Health Tech: A chat with Whoop's new chief medical officer, an update on CMS health tech initiative, and more.

Jul 28, 2026·read at STAT ↗RegulatoryNeutral

STAT PlusNewsletterHealth Tech Newsletter Three questions with Whoop’s new CMO You’re reading the web edition of STAT Health Tech newsletter Manage alerts for this article Email this article Share this article By Mario AguilarJuly 28, 2026 Health Tech Correspondent Mario Aguilar[email protected]Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers!Advertisement Today, the latest on tech company pledges to CMS.

Plus: ChatGPT Health is now generally available and Whoop’s new CMO answers my questions. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%!

2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In health tech, Health Tech Newsletter, STAT+ Submit a correction requestReprints Mario Aguilar Health Tech Correspondent Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter.

You can reach Mario on Signal at mariojoze.13. STAT+ Newsletter A hitchhiker's guide to the health care AI galaxy Recommended Health Tech Newsletter July 23, 2026 STAT Plus: HHS to convene experts on standards for clinical AI Health Tech Newsletter July 21, 2026 Is there an exodus underway at Epic? Advertisement Health Tech Newsletter July 16, 2026 STAT Plus: Medicare wants to shake up how it pays for clinical AI Health Tech Newsletter July 9, 2026 STAT Plus: OpenEvidence backs study that finds it beats LLMs Health Tech Newsletter July 7, 2026 STAT Plus: ‘Secret shopper’ study probes GLP-1 telehealth sites Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
434 words · retrieved 9h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 4h agoSix key issues we’re watching at Fauci’s hearingSTAT
  • 6h agoVisa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warnSTAT
  • 6h agoSTAT+: Bracing for another Fauci hearingSTAT
  • 9h agoSTAT+: GSK lays out plans to cut costs, pursue more late-stage drug trialsSTAT
  • 9h agoSTAT+: FDA staff reiterate concerns about Replimune skin cancer treatmentSTAT